Joint effects of febrile acute infection and an interferon-γ polymorphism on breast cancer risk

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Su, Yi ^a   Tang, Lu Ying ^a   Chen, Li Juan ^a   He, Jian Rong ^a   Su, Feng Xi ^a   Lin, Ying ^a   Chen, Wei Qing ^a   Xie, Xiao Ming ^a   Ren, Ze Fang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FEVER; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INTERFERON GAMMA GENE; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; BREAST TUMOR; GENETIC POLYMORPHISM; GENETICS; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; METABOLISM; RISK; STATISTICAL MODEL;

BREAST NEOPLASMS; CHINA; FEMALE; FEVER; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; LOGISTIC MODELS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84862074191     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037275     Document Type: Article

References (54)

1. Hoption Cann SA, van Netten JP, van Netten C, (2006) Acute infections as a means of cancer prevention: opposing effects to chronic infections? Cancer Detect Prev 30: 83-93.
2. Hoption Cann SA, van Netten JP, van Netten C, Glover DW, (2002) Spontaneous regression: a hidden treasure buried in time. Med Hypotheses 58: 115-119.
3. Kleef R, Jonas WB, Knogler W, Stenzinger W, (2001) Fever, cancer incidence and spontaneous remissions. Neuroimmunomodulation 9: 55-64.
4. Hobohm U, (2001) Fever and cancer in perspective. Cancer Immunol Immunother 50: 391-396.
5. Hobohm U, (2005) Fever therapy revisited. Br J Cancer 92: 421-425.
6. Kolmel KF, Pfahlberg A, Mastrangelo G, Niin M, Botev IN, et al. (1999) Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of Cancer. Melanoma Res 9: 511-519.
7. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, et al. (1999) Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82: 155-160.
8. Hoption Cann SA, van Netten JP, van Netten C, (2003) Dr William Coley and tumour regression: a place in history or in the future. Postgrad Med J 79: 672-680.
9. Mastrangelo G, Fadda E, Milan G, (1998) Cancer increased after a reduction of infections in the first half of this century in Italy: etiologic and preventive implications. Eur J Epidemiol 14: 749-754.
10. Yang L, Parkin DM, Li L, Chen Y, (2003) Time trends in cancer mortality in China: 1987-1999. Int J Cancer 106: 771-783.
11. Hasday JD, Fairchild KD, Shanholtz C, (2000) The role of fever in the infected host. Microbes Infect 2: 1891-1904.
12. Roberts NJ Jr, (1991) Impact of temperature elevation on immunologic defenses. Rev Infect Dis 13: 462-472.
13. Karalyan Z, Zakaryan H, Sargsyan K, Voskanyan H, Arzumanyan H, et al. (2012) Interferon status and white blood cells during infection with African swine fever virus in vivo. Vet Immunol Immunopathol 145: 551-555.
14. Kida Y, Tsuji-Kawahara S, Ostapenko V, Kinoshita S, Kajiwara E, et al. (2006) Increased liver temperature efficiently augments human cellular immune response: T-cell activation and possible monocyte translocation. Cancer Immunol Immunother 55: 1459-1469.
15. Basu S, Srivastava PK, (2003) Fever-like temperature induces maturation of dendritic cells through induction of hsp90. Int Immunol 15: 1053-1061.
16. Aabye MG, Ravn P, Johansen IS, Eugen-Olsen J, Ruhwald M, (2011) Incubation of whole blood at 39 degrees C augments gamma interferon (IFN-gamma)-induced protein 10 and IFN-gamma responses to Mycobacterium tuberculosis antigens. Clin Vaccine Immunol 18: 1150-1156.
17. Ostberg JR, Repasky EA, (2006) Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immunother 55: 292-298.
18. Atanackovic D, Nierhaus A, Neumeier M, Hossfeld DK, Hegewisch-Becker S, (2002) 41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases. Cancer Immunol Immunother 51: 603-613.
19. Netea MG, Kullberg BJ, Van der Meer JW, (2000) Circulating cytokines as mediators of fever. Clin Infect Dis 31 (Suppl 5): S178-184.
20. Dinarello CA, Bernheim HA, Duff GW, Le HV, Nagabhushan TL, et al. (1984) Mechanisms of fever induced by recombinant human interferon. J Clin Invest 74: 906-913.
21. Morimoto A, Murakami N, Takada M, Teshirogi S, Watanabe T, (1987) Fever and acute phase response induced in rabbits by human recombinant interferon-gamma. J Physiol 391: 209-218.
22. Dinarello CA, (1999) Cytokines as endogenous pyrogens. J Infect Dis 179 (Suppl 2): S294-304.
23. Lane HC, Fauci AS, (1985) Immunologic reconstitution in the acquired immunodeficiency syndrome. Ann Intern Med 103: 714-718.
24. Kurzrock R, Quesada JR, Rosenblum MG, Sherwin SA, Gutterman JU, (1986) Phase I study of i.v. administered recombinant gamma interferon in cancer patients. Cancer Treat Rep 70: 1357-1364.
25. He YF, Wang XH, Zhang GM, Chen HT, Zhang H, et al. (2005) Sustained low-level expression of interferon-gamma promotes tumor development: potential insights in tumor prevention and tumor immunotherapy. Cancer Immunol Immunother 54: 891-897.
26. Ruiz-Ruiz C, Munoz-Pinedo C, Lopez-Rivas A, (2000) Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program. Cancer Res 60: 5673-5680.
27. Harigai M, Kawamoto M, Hara M, Kubota T, Kamatani N, et al. (2008) Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B. J Immunol 181: 2211-2219.
28. Kim K, Cho SK, Sestak A, Namjou B, Kang C, et al. (2010) Interferon-gamma gene polymorphisms associated with susceptibility to systemic lupus erythematosus. Ann Rheum Dis 69: 1247-1250.
29. Erdei E, Kang H, Meisner A, White K, Pickett G, et al. (2010) Polymorphisms in cytokine genes and serum cytokine levels among New Mexican women with and without breast cancer. Cytokine 51: 18-24.
30. Gregson AL, Mackowiak PA, (2004) Pathogenesis of fever. In: Cohen J, Powderly WG, editors. Infectious diseases 2nd ed New York Mosby.
31. Dickson JA, (1979) Hyperthermia in the treatment of cancer. Lancet 1: 202-205.
32. Trieb K, Sztankay A, Amberger A, Lechner H, Grubeck-Loebenstein B, (1994) Hyperthermia inhibits proliferation and stimulates the expression of differentiation markers in cultured thyroid carcinoma cells. Cancer Lett 87: 65-71.
33. Zhang HG, Mehta K, Cohen P, Guha C, (2008) Hyperthermia on immune regulation: a temperature's story. Cancer Lett 271: 191-204.
34. Falk MH, Issels RD, (2001) Hyperthermia in oncology. Int J Hyperthermia 17: 1-18.
35. van der Zee J, (2002) Heating the patient: a promising approach? Ann Oncol 13: 1173-1184.
36. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, et al. (2002) Hyperthermia in combined treatment of cancer. Lancet Oncol 3: 487-497.
37. Abel U, Becker N, Angerer R, Frentzel-Beyme R, Kaufmann M, et al. (1991) Common infections in the history of cancer patients and controls. J Cancer Res Clin Oncol 117: 339-344.
38. Kolmel KF, Gefeller O, Haferkamp B, (1992) Febrile infections and malignant melanoma: results of a case-control study. Melanoma Res 2: 207-211.
39. Grossarth-Maticek R, Frentzel-Beyme R, Kanazir D, Jankovic M, Vetter H, (1987) Reported herpes-virus-infection, fever and cancer incidence in a prospective study. J Chronic Dis 40: 967-976.
40. Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, et al. (2000) High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 92: 1260-1266.
41. Goggins W, Gao W, Tsao H, (2004) Association between female breast cancer and cutaneous melanoma. Int J Cancer 111: 792-794.
42. Ho WL, Comber H, Hill AD, Murphy GM, (2011) Malignant melanoma and breast carcinoma: a bidirectional correlation. Ir J Med Sci 180: 901-903.
43. Miller CH, Maher SG, Young HA, (2009) Clinical Use of Interferon-gamma. Ann N Y Acad Sci 1182: 69-79.
44. Karakus N, Kara N, Ulusoy AN, Ozaslan C, Bek Y, (2011) Tumor necrosis factor alpha and Beta and interferon gamma gene polymorphisms in Turkish breast cancer patients. DNA Cell Biol 30: 371-377.
45. Kamali-Sarvestani E, Merat A, Talei AR, (2005) Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer. Cancer Lett 223: 113-119.
46. Scola L, Vaglica M, Crivello A, Palmeri L, Forte GI, et al. (2006) Cytokine gene polymorphisms and breast cancer susceptibility. Ann N Y Acad Sci 1089: 104-109.
47. Gonullu G, Basturk B, Evrensel T, Oral B, Gozkaman A, et al. (2007) Association of breast cancer and cytokine gene polymorphism in Turkish women. Saudi Med J 28: 1728-1733.
48. He JR, Chen LJ, Su Y, Cen YL, Tang LY, et al. (2012) Joint effects of Epstein-Barr virus and polymorphisms in interleukin-10 and interferon-gamma on breast cancer risk. J Infect Dis 205: 64-71.
49. Jurek AM, Greenland S, Maldonado G, Church TR, (2005) Proper interpretation of non-differential misclassification effects: expectations vs observations. Int J Epidemiol 34: 680-687.
50. Lee HC, Chang TY, Yeung CY, Chan WT, Jiang CB, et al. (2010) Association of interferon-gamma gene polymorphisms in Taiwanese children with biliary atresia. J Clin Immunol 30: 68-73.
51. He JR, Chen LJ, Su Y, Cen YL, Tang LY, et al. (2011) Joint Effects of Epstein-Barr Virus and Polymorphisms in Interleukin-10 and Interferon-gamma on Breast Cancer Risk. J Infect Dis 205: 64-71.
52. He JR, Tang LY, Yu DD, Su FX, Song EW, et al. (2011) Epstein-Barr virus and breast cancer: serological study in a high-incidence area of nasopharyngeal carcinoma. Cancer Lett 309: 128-136.
53. Rothman KJ, (1976) The estimation of synergy or antagonism. Am J Epidemiol 103: 506-511.
54. Ren ZF, Liu WS, Qin HD, Xu YF, Yu DD, et al. (2010) Effect of family history of cancers and environmental factors on risk of nasopharyngeal carcinoma in Guangdong, China. Cancer Epidemiol 34: 419-424.